B
ELV icon

Baird’s Elevance Health ELV Stock Holding History

Baird’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$895K Buy
5,798
+2,195
+61% +$313K 0.01% 778
2014
Q4 		$453K Buy
+3,603
New +$445K ﹤0.01% 978
2014
Q1 		– Sell
-2,232
Closed -$206K – 1121
2013
Q4 		$206K Buy
+2,232
New +$198K ﹤0.01% 1062

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Baird's ELV Position: Q1 2015 in Review

Baird increased its Elevance Health (ELV) stake by 61% in Q1 2015, buying an estimated $313K and bringing the position to 5,798 shares worth $895K. The position accounts for 0.01% of the portfolio, ranked #778.

Baird first reported a position in ELV in Q4 2013 and has held it in 3 quarters since. 752 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

  • Baird held 5,798 shares of Elevance Health worth $895K as of Q1 2015.
  • Baird bought 2,195 Elevance Health shares in Q1 2015, an estimated $313K.
  • Elevance Health made up 0.01% of Baird's portfolio in Q1 2015, its #778 holding.
  • Baird first reported a position in Elevance Health in Q4 2013 and has held it in 3 quarters since.
  • 752 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.